We cannot discard a possible association between the methylation status of other CG sites along the TBX15 promoter and the expression of TBX15. Of interest, methylation status of the TBX15 promoter related to clinicopathological features of prostate cancer was reported, although the study did not mention TBX15 expression [14]. The gene discussed is TBX15; the disease is prostate cancer.